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Excitation-contraction (EC) coupling in striated muscles is
mediated by the cardiac or skeletal muscle isoform of voltage-
dependent L-type Ca2 channel (Cav1.2 and Cav1.1, respec-
tively) that senses a depolarization of the cell membrane, and in
response, activates its corresponding isoform of intracellular
Ca2 release channel/ryanodine receptor (RyR) to release stored
Ca2, thereby initiatingmuscle contraction. Specifically, in car-
diac muscle following cell membrane depolarization, Cav1.2
activates cardiac RyR (RyR2) through an influx of extracellular
Ca2. In contrast, in skeletal muscle, Cav1.1 activates skeletal
muscle RyR (RyR1) through a direct physical coupling that
negates the need for extracellular Ca2. Since airway smooth
muscle (ASM) expresses Cav1.2 and all three RyR isoforms, we
examined whether a cardiac muscle type of EC coupling also
mediates contraction in this tissue.We found that the sustained
contractions of ratASMpreparations inducedbydepolarization
withKClwere indeed partially reversed (40%) by 200M ryan-
odine, thus indicating a functional coupling of L-type channels
andRyRs inASM.However, KCl still caused transientASMcon-
tractions and stored Ca2 release in cultured ASM cells without
extracellular Ca2. Further analyses of rat ASM indicated that
this tissue expresses as many as four L-type channel isoforms,
including Cav1.1. Moreover, Cav1.1 and RyR1 in rat ASM cells
have a similar distribution near the cell membrane in rat ASM
cells and thus may be directly coupled as in skeletal muscle.
Collectively, our data implicate that EC-coupling mechanisms
in striated muscles may also broadly transduce diverse smooth
muscle functions.
In cardiac muscle and in skeletal muscle, depolarization of
the cell membrane causes voltage-dependent L-type Ca2
channels localized to the cell membrane to activate the juxta-
posing intracellular Ca2 release channels known as ryanodine
receptors (RyRs)2 (1, 2). The massive release of Ca2 from the
sarcoplasmic reticulum into the cytosol by activated RyRs then
initiates a series of Ca2-dependent events that result in the
cross-bridging of actin andmyosin filaments, thereby complet-
ing the vital process of excitation-contraction (EC) coupling.
The critical step of RyR activation by the L-type channels dur-
ing EC coupling, however, differs between cardiac muscle and
skeletal muscle. Specifically, in skeletal myocytes, the skeletal
muscle isoform of L-type channel (Cav1.1) activates its corre-
sponding isoform of RyR (RyR1) through direct physical cou-
pling between the voltage-sensing, pore-forming 1 subunit
(Cav1.11 or 1S) and the cytoplasmic domain of RyR1 (3, 4). In
contrast, in cardiacmyocytes, the cardiac RyR (RyR2) is activated
by an influx of extracellularCa2 through the1 subunit ofCav1.2
(Cav1.21 or 1C). Cardiac type of EC coupling therefore requires
extracellular Ca2 (i.e. Ca2-induced Ca2 release), unlike the
skeletal muscle type of EC coupling (2, 5).
An emerging body of literature now indicates that RyRs
expressed in various smooth muscle types mediate many impor-
tant pathophysiological processes. These processes include air-
way constriction (bronchoconstriction) (6, 7), the hallmark of
asthma, and hypoxia-induced pulmonary vasoconstriction (8,
9), which enables ventilation-perfusion matching in the lung.
However, unlike cardiac muscle or skeletal muscle that
expresses one dominant RyR isoform, many smooth muscle
types, including those in the airway, pulmonary and systemic
vasculatures, and gastrointestinal tract, express all three RyR
isoforms (7, 10–13). Existing data suggest that individual RyR
isoforms in these smooth muscle tissues do not share the same
activating mechanism (7, 10, 12, 14). However, how individual
RyR isoforms are regulated in various smooth muscle tissues
remains largely unknown.
Although recent studies have suggested that endogenous
molecules such as cyclic ADP-ribose and FK506-binding pro-
teins play a role in regulating stored Ca2 release by RyRs in the
airway smooth muscle (ASM) and in other smooth muscle
types (14, 15), Cav1.2 and Cav1.1 remain the most firmly estab-
lished physiological regulators of RyR2 and RyR1, respectively.
Moreover, recent studies of ASM (7) and pulmonary arterial
smoothmuscle (11, 12) have shown that RyR1 and RyR2 appear
to localize to portions of sarcoplasmic reticulum juxtaposing
the cell membrane, thus raising the possibility that these RyR
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isoforms in certain smooth muscle types may also be function-
ally linked to the L-type channels in the cell membrane as in
striatedmuscles. It is noteworthy that both L-type channels and
RyRs in ASM and pulmonary arterial smooth muscles have
been shown to mediate bronchoconstriction and hypoxia-in-
duced pulmonary vasoconstriction (8, 9, 16–19), respectively.
At present, it is not known whether L-type channels and
RyRs mobilize Ca2 independently or jointly to mediate these
processes.
Since Cav1.2 is expressed in various smooth muscle types
(20–22), we examined whether a cardiac muscle type of EC
coupling in ASM may mediate contraction in this tissue. Here
we report that the sustained, depolarization (KCl)-induced
contractions of rat ASM preparations indeed were partially
reversed by ryanodine, which specifically interacts with RyRs
(1, 23), thus indicating the existence of EC coupling involving
the L-type channels and RyRs in this tissue. However, in the
absence of extracellular Ca2, KCl still caused transient con-
tractions of these ASM preparations as well as Ca2 release in
cultured ASM cells. These data thus suggest the (co)existence
of a skeletal muscle type EC-coupling mechanism in ASM. Our
subsequent characterizations of the airway smooth muscle
indicate that, in addition to Cav1.2, rat ASM expresses three
other isoforms of L-type channels, as defined by their 1 sub-
units. Moreover, Cav1.1 and RyR1 in rat ASM cells share a sim-
ilar distribution near the cell membrane, thus suggesting a pos-
sible direct functional coupling between these two channels as
in skeletalmuscle. Collectively, our data indicate thatASMpos-
sesses every Ca2 channel required for EC coupling in skeletal
and cardiac muscles and thus suggest that EC-coupling mech-
anisms in striated muscles may also broadly transduce diverse
smooth muscle functions.
EXPERIMENTAL PROCEDURES
Materials—The mouse monoclonal anti-Cav1.11 antibody
and an anti-RyR antibody that recognizes RyR2 were obtained
from Affinity BioReagents Inc (Golden, CO). Rabbit polyclonal
anti-Cav1.21 and anti-Cav1.31 antibodies and their corre-
sponding absorbing peptides were purchased from Calbio-
chem. The isoform specificities of anti-Cav1.21, anti-Cav1.31
were reported previously (7, 24). The isoform specificity of anti-
Cav1.11 antibody is shown in Fig. 4A. A rabbit polyclonal
anti-RyR1 antibody was raised against a synthetic peptide
(CFIKGLDSFSGKPRGSG) and purified on peptide affinity col-
umn using a method similar to a method as described previ-
ously (25). The isoform specificity of the anti-RyR1 antibody
was confirmed using rat heart homogenate and recombinantly
expressed RyR3 protein as negative controls for RyR2 and
RyR3, respectively (data not shown). Species-specific fluoresce-
in-conjugated goat anti-mouse IgG and rhodamine-conjugated
goat anti-rabbit IgG secondary antibodies were obtained from
Jackson ImmunoResearch Laboratories (West Grove, PA).
Ca2 indicator Fura-2 acetoxymethyl ester was obtained from
Molecular Probes (Eugene,OR). Cy3-conjugatedmousemono-
clonal anti-smoothmuscle-specific-actin IgG, ryanodine, and
all other reagents were obtained from Sigma unless specified
otherwise.
Depolarization-induced Contractile Responses of Rat ASM
Preparations (Bronchial Rings)—Male Wistar rats (200–300
gm)were obtained fromCharles River Laboratories. In a typical
experiment, four second and third generation bronchial rings
(inner diameter, 1 mm, and length, 3 mm) were isolated
from each animal, dissected free of adventitial tissues, and stud-
ied in parallel as described previously (7). Briefly, each bron-
chial ring was mounted horizontally on two tungsten triangles
and immersed in modified Krebs-Henseleit buffer (KHB, in
mM, 118 NaCl, 4.8 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2.5 CaCl2, 25
NaHCO3, and 11 glucose, pH 7.4) warmed to 37 °C in a ther-
mostated organ bath. The triangles (and thus the bronchial
ring) were suspended between a stainless steel wire hook con-
nected to a Grass FT-03 force displacement transducer (Grass-
Telefactor,WestWarwick, RI) and a glass hook inside the organ
bath that served as an anchor. An optimal resting tension of 0.5
gm was applied to each ring during the initial equilibration
period of 30 min, and the subsequent changes in isometric ten-
sion were amplified and recorded continuously (Polyview soft-
ware, Grass-Telefactor). After the equilibration period, the
bronchial ringswere submaximally constrictedwith 40mMKCl
or maximally constricted with 80 mM KCl over 10 min to allow
the contraction to reach steady state before adding 200 M
ryanodine to inhibit RyRs (1, 23).
In experiments to determine whether KCl could induce con-
tractile responses in rat bronchial rings without extracellular
Ca2, rat bronchial rings preconstricted with 40 or 80 mM KCl
for30minwere relaxed to the baseline bywashing off highK
KHB with 3 volumes of modified KHB. After equilibration for
another 10–20 min, the modified KHB was switched to Ca2-
free KHB (in mM, 118 NaCl, 4.8 KCl, 1.2 MgSO4, 1.2 KH2PO4,
25 NaHCO3, 11 glucose, and 0.5 EGTA, pH 7.4) for 2 min
before the rat bronchial rings were rechallenged with 80 or 40
mM KCl.
Depolarization-induced Ca2 Responses of Rat ASM Cell in
the Presence or Absence of Extracellular Ca2—ASM cells were
isolated from the second and third generation of rat bronchi
and cultured using a method described previously (7). After
confirming that the majority (98%) of these cells expressed
smooth muscle-specific -actin, cells between two and four
passages were grown in M199 media containing 10% fetal
bovine serum over 7–8 days in culture dishes (MatTek, Ash-
land, MA) designed for live cell imaging. The ASM cells were
first loaded with 5 M Fura-2 acetoxymethyl ester in M199
media containing 10% fetal bovine serum for 30 min and then
washed with modified KHB three times to remove excess Ca2
indicator. In certain experiments, the ASM cells were washed
twice more with Ca2-free KHB. The culture dish was then
placed onto a stagemounted on an invertedmicroscope (Nikon
Eclipse TE2000). The ASM cells were excited alternatively at
340 and 380 nm under ambient temperature (21 °C), and fluo-
rescence measurements were performed on small groups of
cells viewed with a Nikon UV-Fluor 40 oil-immersion objec-
tive as described previously (7). After an initial equilibration
period of 2 min, 40 mM KCl was introduced, and the Ca2
responses of ASM cells, in the presence or absence of extracel-
lular Ca2, were reflected as changes in fluorescence ratio
(F340/F380) of Fura-2 averaged from pixels within cytoplasmic
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areas and recorded at 1-s intervals (7, 26). Each group of ASM
cells were challenged with KCl only once.
Immunoblot Analyses of Cav11 and RyR Isoforms in Rat
ASM—Second and third generation bronchi and trachea from
rats were cleaned of adventitial tissues, pooled, and homoge-
nized in a buffer consisting of 320 mM sucrose, 5 mM HEPES,
and a protease inhibitor mixture (Complete Mini, Roche
Applied Science) using a handheld tissue homogenizer. Mem-
branous fractions enriched in Ca2 channels were prepared
fromhomogenates of ratASM, skeletalmuscle, heart, and brain
tissues as described previously (7). The protein concentrations
were determined using a Bio-Rad DC protein assay kit using
albumin as a standard. Approximately 20–40 g of microso-
mal ASM protein samples were separated by 7% or 3–8% gra-
dient Tris acetate SDS-PAGE under reducing conditions and
transferred onto polyvinylidene fluoride membranes over 2 h.
The membranes were first blocked with 5% nonfat milk in
0.05% Tween 20, phosphate-buffered saline (PBS) at 24 °C for
1 h. Following probing with anti-Cav1.11 (1 ng/l), anti-
Cav1.21 (1.5 ng/l), anti-Cav1.31 (5 ng/l), anti-RyR1
(1:100), and anti-RyR2 antibodies (7) overnight, the blots were
developed using a Vectastain ABC-AmP Western blot detec-
tion kit (Vector Laboratories, Burlingame, CA) (7). To verify
that protein bands observed in the immunoblots are indeed the
isoforms of 1 subunit of L-type channel, in certain experi-
ments, the anti-Cav1.21 and anti-Cav1.31 antibody were pre-
incubated with 1.5 ng/l and 3.5 ng/l corresponding absorb-
ing peptide for 1 h before application (24).
RT-PCR Analyses of 1 Subunit of L-type Channel (Cav11)
and RyR Isoforms in Rat ASM—After removing adventitial and
epithelial tissues, airway smooth muscle layers from trachea
and large bronchi of each animal were pooled, and total RNA
was extracted using the Qiagen RNeasy mini kit (Qiagen Inc.,
Carlsbad, CA) using a method described previously (7, 26). For
real-time RT-PCR analysis of Cav11 isoforms, the first-strand
cDNAswere synthesized from200ng of RNA fromeach sample
using the Qiagen Sensiscript RT kit and resulted in a final sam-
ple volume of 40l. After initial trials with different amounts of
starting cDNAs, we amplified 2 l of cDNAs from each sample
using the iQ SYBR Green Supermix and the iCycler iQ real-
time PCR detection system (Bio-Rad Laboratories, Inc.). The
isoform-specific forward and reverse primers are listed inTable
1. Rat -actin was also amplified and used as an internal refer-
ence (10). The real-time PCR was run for one cycle at 95 °C for
3 min followed immediately by 40–45 cycles at 95 °C for 30 s,
56 °C for 30 s, and 72 °C for 60 s. The fluorescence was meas-
ured after each of the repetitive cycles. The PCR products for
individual Cav11 isoforms amplified after 40 cycles were veri-
fied by electrophoresis and sequencing analyses (performed by
DukeUniversityDNASequencing Facility). Similarly, real-time
RT-PCR analyses of RyR isoforms in rat ASM were performed
using a protocol and isoform-specific primers described previ-
ously (7, 10).
Immunohistochemical Studies of Cav11 Isoforms in Rat
Airways—Rat lung tissues were resected from euthanized ani-
mals, immediately immersed in Tissue-Tek optimum cutting
temperature compound (Sakura Finetek, Torrance, CA), and
rapidly frozen in liquid nitrogen. Five-M sections were cut
onto glass slides and stored in20 °C until the day of study. For
immunohistochemical studies, the lung sections were dried in
room temperature over 10 min, fixed with 2% paraformalde-
hyde in PBS (pH7.4) for 10min, andwashedwith PBS twomore
times. Subsequently, the tissue sections were quenched with
0.75% glycine and then permeabilized in 0.01% SDS and 0.1%
Triton-X in PBS for 30 min. Before probing with individual
antibody specific for each isoform of Cav11, the lung sections
were treated using the M.O.M. kit (Vector Laboratories)
according to the manufacturer’s instructions to reduce back-
ground staining from endogenous immunoglobulins in the
lung tissues. The dilutions for each of the antibodies were 1
ng/l, 1.5 ng/l, and 3.5 ng/l for anti-Cav1.11, anti-Cav1.21,
and anti-Cav1.31, respectively. After incubation with individ-
ual primary antibody for 1 h, the slides were stained using a
VectaStain Elite kit (Vector Laboratories) according to the
manufacturer’s instructions. As with our immunoblot analyses,
in certain experiments, the anti-Cav1.21 antibody and anti-
Cav1.31 antibody were preincubated with the corresponding
absorbing peptides before application (24). Each experiment
also contained at least one control in which only the primary
antibody was omitted. Small pieces of muscles from the hind
leg, cardiac ventricle, and cardiac atria were used as positive
control tissues for Cav1.11, Cav1.21, and Cav1.31, respec-
tively (27). The slides were examined and digitally photo-
graphed using a microscope (Olympus BX60) equipped with
UPlanFl 10–20 objectives.
Immunofluorescence Study of RyR1 and Cav1.1 in Cultured
Rat ASM Cells—To determine whether RyR1 and Cav1.1 are
expressed in close proximity in rat ASM cells and therefore
could be physically coupled as in skeletal muscle, immunofluo-
rescence studies using the rabbit polyclonal anti-RyR1 (1:100
dilution) and the mouse monoclonal anti-Cav1.11 (1 ng/l)
were performed on non-overlapping, elongated rat ASM cells
(8 days old, third passage) using a method described previ-
ously (7). The ASM cells all expressed smooth muscle-specific
-actin, hadKCl-inducedCa2 responses (see Fig. 3), and had a
similar RyR and Cav11 mRNA expression profile as intact rat
ASM (see Fig. 7A). After double labeling with both primary
antibodies, these cells were probed with species-specific fluo-
rescein-conjugated goat anti-mouse IgG (7.5 ng/l) and rhoda-
mine-conjugated goat anti-rabbit IgG secondary antibodies
(7.5 ng/l) in 1% goat serum/PBS for 1 h before mounting on
ProLong antifade solution (Molecular Probes). Control slides
were prepared similarly except that primary antibodies were
omitted. The prepared slides were then examined using a Carl
Zeiss LSM 510 laser scanning confocal microscopy system
attached to anAxiovert 100 invertedmicroscope equippedwith
a 100 objective as described previously (7).
Data Analysis—All results are expressed as means  S.E.
Significance of differences of data were analyzed with Stu-
dent’s t test. A p value of  0.05 was considered statistically
significant.
RESULTS
Partial Reversal of KCl-induced Contractions of Rat ASM
Preparations by Ryanodine—In rat bronchial rings maximally
contractedwith 80mMKCl, the contractile responses were sus-
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tained for more than 1 h (Fig. 1A, top trace). In contrast, inhi-
bition of RyRs by adding 200 M ryanodine (1, 23) caused a
partial relaxation that continued over 30 min before stabiliza-
tion (Fig. 1A, middle trace). The KCl-induced contractions of
bronchial rings are mediated by voltage-dependent L-type
channels (28) as the L-type channel blocker diltiazem (10 M)
completely reversed the contraction (Fig. 1A, bottom trace). In
bronchial rings submaximally contracted by 40 mM KCl (Fig.
1B), 200 M ryanodine caused an additional transient contrac-
tion before the partial relaxation. This biphasic response of sub-
maximally contracted bronchial rings to ryanodine is likely due
to some remaining storedCa2 release byRyRs inASMas ryan-
odine entering the ASM activates RyRs at lower concentrations
(1). The biphasic responses of rat bronchial rings to ryanodine
were observed in every submaximally contracted ring but never
in maximally contracted bronchial rings (n  5 in each group).
At steady state (1 h after applying KCl), ryanodine signifi-
cantly reversed the initial KCl-induced contraction in both 80
mMand 40mMKCl-contracted rat bronchial rings by 38.8 4.5
and 42.3  2.7%, respectively (Fig. 1C, p  0.001 versus the
corresponding control groups). These data thus indicate a func-
tional coupling of L-type channels
and RyRs in the depolarization/
KCl-induced contractions of rat
ASM preparations.
Depolarization-induced Transi-
ent Contractions of Rat ASM Prepa-
rations in the Absence of Extracellu-
lar Ca2—Since the effect of 200
M ryanodine on KCl-contracted
bronchial rings indicates the exist-
ence of EC coupling in ASM and
Cav1.2 is thought to be the main L-
type isoform in smooth muscle tis-
sues (20–22), we examined whether
extracellular Ca2 is essential for
KCl-induced contractions of rat
ASM preparations. This require-
ment for extracellular Ca2 would
support the notion that EC coupling
in the ASM is entirely mediated by
an influx of Ca2 (via L-type chan-
nels) that subsequently activates
RyRs analogous to the cardiac mus-
cle type of EC coupling (i.e. Ca2-
induced Ca2 release) (2). Unex-
pectedly, every rat bronchial ring
contracted in response to 40 or 80
mM KCl in the absence of extracel-
lular Ca2 (and in the presence of
0.5mM EGTA, n 8 in each group).
However, the contractile responses
of these bronchial rings without ex-
tracellular Ca2 were transient and
smaller than the corresponding
contractile responses in the pres-
ence of extracellular Ca2 (Fig. 2B).
The peak KCl-induced contractile
responses of bronchial rings in the absence of extracellular
Ca2 were 79.9  3.2% of the corresponding responses in the
presence of extracellular Ca2 in the 80 mM KCl group and
41  5.2% in the 40mMKCl group (Fig. 2B). Moreover, most of
the KCl-induced contractions in the absence of extracellular
Ca2 ended within 5 min, suggesting that extracellular Ca2 is
needed to replenish intracellular Ca2 stores. Nevertheless,
these data suggest that depolarization of ASM cell membrane
causes stored Ca2 release in rat ASM without extracellular
Ca2, thus suggesting the (co)existence of a skeletal muscle
type of EC coupling in ASM.
Depolarization-induced Stored Ca2 Release in Cultured Rat
ASM Cells in the Absence of Extracellular Ca2—To confirm
that KCl-induced contractions of ASM preparations in the
absence of extracellular Ca2 are due to storedCa2 release, we
directly monitored intracellular Ca2 concentrations ([Ca2]i)
of cultured ASM cells isolated from second and third genera-
tions of rat bronchi. The majority (98%) of these ASM cells
expressed smooth muscle cell-specific -actin. We subse-
quently found that these culturedASMcells expressed a similar
profile of Ca2 channel mRNAs as ASM tissue even after five
FIGURE 1. Partial reversal of depolarization-induced contractions of rat ASM preparations by inhibiting
RyRs. Rat bronchial rings were maximally contracted by 80 mM KCl (A) or submaximally contracted by 40 mM
KCl (B). As compared with time controls (top traces), adding 200 M ryanodine (middle traces) caused a gradual
relaxation of rat bronchial rings. In the submaximally contracted bronchial rings, ryanodine caused a transient
contraction before the gradual relaxation. Adding the L-type channel blocker 10 M diltiazem completely
relaxed the KCl-contracted bronchial rings (lower traces). Combined data of maximally (A, bottom panel) and
submaximally (B, bottom panel) contracted bronchial rings in response to ryanodine or diltiazem at steady state
(mean  S.E., n  5 in each group). *, p  0.005, and **, p  0.001 versus corresponding time control groups.
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passages (see Figs. 5B and 7A). The changes in [Ca2]i of these
cells were reflected by changes in the fluorescence ratio of
Fura-2 (F340/F380) averaged from pixels within cytoplasmic
areas. In the presence of extracellularCa2, 40mMKCl typically
induced a large initial Ca2 transient but then maintained a
stable Ca2 above the resting state (n 49, Fig. 3A, solid trace).
In ASM cells depolarized with 40 mM KCl in the absence of
extracellular Ca2 (n  25), the peak increases in [Ca2]i were
significantly lower than those in cells in the presence of extra-
cellular Ca2 (Fig. 3, A and B).
Expression of Multiple L-type Channel and RyR Isoforms in
the Rat Airways—The ex vivo studies of rat ASM preparations
and cultured ASM cells both suggest that EC coupling in ASM
is not completely dependent on extracellular Ca2, thus indi-
cating the (co)existence of skeletal muscle type EC coupling in
this tissue. Since all three RyR isoforms are expressed in mouse
ASM (7), we used immunoblot techniques to examine the
membranous fractions of rat ASM homogenate for L-type
channel isoforms thatmay transduce the skeletalmuscle type of
EC coupling in this tissue. Commercially available antibodies
that recognize individual isoforms of voltage-sensing, pore-
forming 1 subunit (Cav11), which
defines the L-type channel isoform,
were used. Rat skeletal muscle,
heart, and brain were used as posi-
tive control tissues for Cav1.11,
Cav1.21, and Cav1.31, respec-
tively (24, 29). Cav1.41 was not
included in our immunoblot studies
due to the lack of availability of an
isoform-specific antibody. In posi-
tive control tissues (Fig. 4, A–C),
each Cav11 isoform appeared as
double bands with molecular
masses of 200 kDa in immuno-
blots, indicating the expression of
both a full-length channel and a
truncated channel, as has been
described previously (24, 29). Rat
ASM also expressed both full-length
and truncated Cav1.21 channels
(Fig. 4B, left panel). In immunoblots
probed with anti-Cav1.21 preincu-
bated with Cav1.21-absorbing pep-
tides (24), the double bands seen in
both ratASMandheart sampleswere
eliminated (Fig. 4B, right panel).
However, rat ASM also expresses
both Cav1.11 and Cav1.31 pro-
teins with molecular masses slightly
above 195 kDa. In ASM, Cav1.11
exists as a truncated protein, but a
faint protein that corresponds to the
full-length channel was also seen in
two out of five experiments (Fig. 4A,
left panel). In certain experiments,
membranous fractions from rat
brain and heart were used as con-
trols to test this anti-Cav1.11 antibody isoform specificity (Fig.
4A, right panel). In contrast toCav1.11 andCav1.21, Cav1.31
in ASM exists only as a full-length channel (n  three inde-
pendent experiments, Fig. 4C, left panel). In immunoblot
experiments in which the anti-Cav1.31 was preincubated with
Cav1.31-absorbing peptides, the protein band in the ASM
sample along with two protein bands in the brain samples were
eliminated (Fig. 4C, right panel) but then surfaced after reprob-
ing these blots with anti-Cav1.31 alone (data not shown).
Another protein band with a molecular mass slightly below 200
kDa in the brain sample was not affected by the Cav1.31-absorb-
ing peptides (Fig. 4C, arrow). The identity of this protein band is
not known. As reported in mouse ASM (7) and rat pulmonary
arterial smooth muscle (11, 12), rat ASM also expresses multiple
isoforms of RyRs. In particular, our immunoblot studies of mem-
branous fractions from rat ASM using anti-RyR antibodies sug-
gested the presence of both RyR1 and RyR2 (Fig. 4D).
To confirm the existence of multiple L-type channel iso-
forms in ASM, including Cav1.11 that may transduce the
depolarization-induced contractions of ASM in the absence of
extracellular Ca2 (Fig. 2), we performed RT-PCR analyses on
FIGURE 2. Contractile responses of rat ASM preparations to KCl in the absence of extracellular Ca2. Rat
bronchial rings were maximally or submaximally contracted with 80 mM (A, top panel) or 40 mM KCl (A, lower
panel), respectively, for 30 min before switching to modified KHB containing 0.5 mM EGTA and without Ca2
as indicated by the top bars. Rat bronchial rings were then rechallenged with KCl (arrows). B, relative peak
contractile responses of rat bronchial rings to 80 or 40 mM KCl in the absence of extracellular Ca2 (mean 
S.E.).
FIGURE 3. Ca2 responses of cultured rat ASM cells to KCl in the absence of extracellular Ca2. A, in
cultured rat ASM cells all expressing smooth muscle-specific -actin, representative Ca2 responses of cul-
tured rat ASM cells to 40 mM KCl in the presence (solid trace) or absence (dotted trace) of extracellular Ca2. KCl
was added at 60 s (arrow). B, combined peak Ca2 responses of cultured ASM cells to 40 mM KCl with or
without extracellular Ca2.
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rat ASM. Real-time RT-PCR analyses of rat ASMusing primers
specific for each rat1 subunit (Table 1) revealedmRNAs for all
four known Cav11 isoforms. The individual RT-PCR products
were verified by electrophoresis and had the expected molecu-
lar weights of 258 (Cav1.11), 232 (Cav1.21), 500 (Cav1.31),
and 445 (Cav1.41) bp (Fig. 5B). The identity of each Cav11
product was further confirmed by sequencing analyses (Table
2). The RT-PCR products of Cav1.21 and Cav1.31, as judged
by their lower detection threshold cycles in the real-time RT-
PCR and in electrophoresis analyses, appear to be more abun-
dant than those of Cav1.11 and Cav1.41 (Fig. 5).
As withmouse ASM (7), RyR1 and RyR2 were detected in rat
ASM (Fig. 4D). Collectively, our data indicate that rat ASM
expresses all of the Ca2 channels (i.e. RyR1, RyR2, Cav1.11,
and Cav1.21) essential for EC coupling in cardiac and skeletal
muscles.
Expression of Multiple Cav11 Isoforms in the Rat ASM—
To confirm that each Cav11 isoform detected by immunoblot
and RT-PCR analyses is expressed
within the ASM layer of bronchi
(and was not due to contamination
by other cell types in the airways),
we performed immunohistochemi-
cal studies on frozen-sectioned rat
lung tissues using individual iso-
form-specific anti-Cav11 antibod-
ies as in our immunoblot studies.
The three 1 isoforms were all
detected within the smooth muscle
layers (as highlighted by a Cy-3-
conjugated anti-smooth muscle-
specific -actin antibody) of large
rat bronchi (Fig. 6, second upper
panel from the left). In addition, anti-Cav1.21 antibody may
also recognize an antigen in the epithelial layer of airway. In
frozen lung sections probed only with the goat anti-mouse IgG
secondary antibody or with the goat anti-rabbit IgG secondary
antibody, only background staining was detected in the airway
(Fig. 6, left lower panels). Moreover, in control experiments in
which the anti-Cav1.21 or anti-Cav1.31 antibody was prein-
cubated with its corresponding absorbing peptides, the immu-
nohistochemical staining of the smooth muscle layers was sig-
nificantly reduced (Fig. 6, right lower panels).
RyR1 and Cav1.11 Are Expressed in Close Proximity in Rat
ASMCells—We and others previously used amouse anti-RyR1
IgM antibody to show that RyR1 is expressed near the cell
membrane of ASM cells (7) and pulmonary arterial smooth
muscle cells (11, 12). To determinewhether RyR1 andCav1.11
are expressed in close proximity in rat ASM cells (and therefore
could be functionally coupled), we performed a co-localization
FIGURE 4. Expression of L-type channel and RyR proteins in rat ASM. Membranous fractions of rat ASM (Aw), heart (Ht), skeletal muscle (Sk), or brain (Br) were
probed with the individual isoform-specific anti-CaV11 antibody labeled below (A, B, and C, left panels). In certain experiments, blots were probed with
anti-CaV1.21 antibody or anti-CaV1.31 antibody preincubated with corresponding absorbing peptides (abs. pept.) as labeled (B and C, right panel). In C, the
arrow indicates the protein band that was not eliminated by anti-CaV1.31-absorbing peptide. Each blot is representative of at least three independent
experiments. RyR1 and RyR2 are expressed in rat ASM as described previously in rat pulmonary arterial smooth muscle (11, 12) and mouse ASM (7) (D).
FIGURE 5. Expression of L-type channel mRNAs in rat ASM. A, real-time RT-PCR analyses using isoform-
specific primers for each Cav11 isoform labeled at the bottom (CaV1.11  1S; CaV1.21  1C; CaV1.31 
1D; and CaV1.4 1  1F) (n  three independent experiments in each group). The PCR products amplified over
40 cycles were subjected to electrophoresis and had the expected molecular weights (B).
TABLE 1
Primers for rat isoforms of 1 subunit of L-type Ca
2 channels
Gene Accession number Primer Sequence 5-3 Nucleotide position Predicted size
bp
Cav1.11 RATCACAI Sense TGTGGTATGTCGTCACTTCCTCC 1193-1215 258
Antisense CGTCAATGATGCTGCCAATG 1450-1431
Cav1.21 NM012517.1 Sense CAAGCCCTCGCAGAGGAATGC 5198-5218 232
Antisense GAAGTTGCTCCTGCTGTCACTC 5429-5408
Cav1.31 NM017298.1 Sense CCATCTCACACCGCCAGGACTATG 6842-6865 500
Antisense CATCACCTTTGACCTCTCTCGTG 7341-7319
Cav1.41 NM053701.1 Sense GATTTGCCCATCCCAGGCACCTAC 5487-5510 445
Antisense CATCAAAGCGGGAGAGAATAGACTC 5931-5907
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study of these two Ca2 channels using immunofluorescence
techniques. In this study, rabbit anti-RyR1 IgGwas used instead
of mouse anti-RyR1 IgM as our control experiments indicated
that the fluorochrome-labeled secondary antibodies could not
reliably distinguish between the mouse IgM (anti-RyR1) and
mouse IgG (anti-Cav1.11) antibodies. These cultured ASM
cells expressed a similar profile of Ca2 channel mRNAs as the
rat ASM (Fig. 7A). As shown in Fig. 7B, RyR1 and Cav1.11
share similar cellular distribution in cultured rat ASM cells.
Near the cell membrane (Fig. 7B, arrows), there were areas of
overlaps between RyR1 and Cav1.11, thus suggesting co-local-
ization and a possible physical coupling of these two channels in
ASM cells.
DISCUSSION
Although Cav1.2 is thought to be the main L-type channel
isoform in smooth muscle tissues (20), herein we describe that
ASM also expresses other isoforms of L-type Ca2 channels,
including the skeletal muscle isoform Cav1.1 (Figs. 4–6). Since
ASM also expresses RyR1 and RyR2 (Figs. 4 and 6) (7), ASM
thus possesses all of the Ca2 channels involved in the EC cou-
pling of striated muscles (30). Moreover, the reversal of depo-
larization-induced rat ASM contractions by RyR inhibition
(200M ryanodine (1, 23)), as shown in Fig. 1, indicates that the
depolarizing signals in the cell membrane of ASM are also
transmitted to the sarcoplasmic reticulum via L-type channels,
thereby leading to stored Ca2 release by RyRs (i.e. EC coupling
in ASM). As our immunofluorescence studies of ASM cells
indicate that RyR1 and Cav1.1 are expressed in close proximity
(Fig. 7) and ASM preparations contracted in response to depo-
larization in the absence of extracellular Ca2 (Fig. 2) (28), our
data collectively suggest the (co)existence of the skeletalmuscle
type of EC coupling in ASM.
Since a previous study has also demonstrated that both RyR1
and RyR2 are essential in the KCl-induced Ca2 responses of
rat portal venous smoothmuscle cells (10), EC-couplingmech-
anisms in striated muscles may exist in other smooth muscle
tissues. As mentioned previously, both L-type channels and
RyRs in various types of smoothmuscle have been implicated in
mediating important pathophysiological processes that include
bronchoconstriction and hypoxia-induced pulmonary vaso-
constriction (8, 9, 16–19). Thus, EC coupling of RyR and L-type
channel may be broadly involved in diverse smooth muscle
functions.
Although the results described herein are from studies using
rat ASM, similar reversal of KCl-induced contractions of ASM
preparations by RyR inhibition (Fig. 1) and expression of mul-
tiple isoforms of L-type channel1 subunit atmRNA level were
also observed in studies of mouse ASM preparations (data not
shown). We chose to focus on rat ASM in this study because
FIGURE 6. Immunohistochemical detection of L-type channel isoform in rat ASM. Rat lung tissues containing large bronchi were probed with individual
isoform-specific anti-CaV11 antibodies (top panels). The individual antigens were detected by 3, 3	-diaminobenzidine staining in ASM (labeled ** and also
highlighted by the immunofluorescence staining for smooth muscle (sm. muscle))-specific -actin). In addition, control experiments were performed in which
only the secondary antibody goat anti-mouse IgG (GAM) or goat anti-rabbit IgG (GAR) was used (left lower panels). In other control experiments, anti-CaV1.21
and anti-CaV1.31 were preincubated with their corresponding absorbing peptides (abs. peptide) as labeled before their application (right lower panels). Each
picture is representative of three independent experiments.
TABLE 2
Partial sequences of the RT-PCR products and the matched rat genes
Product no. Sequence Matched accession no. Nucleotide position Gene
1 5	-GGAACAGATGAACCACATATCGGACATCC RATCACAI 1290-1349 Cav1.11
TCAATGTGGCTTTCACCATCATCTTCACCCT-3	
2 5	-AGGAGGAGCTGGACAAGGCTATGAAGGAG NM012517.1 5302-5361 Cav1.21
GCAGTGTCTGCTGCCTCCGAAGACGACATCT-3	
3 5	-TGGCAGATGAAATGATTTGCATCACCACCT NM017298.1 6932-6991 Cav1.31
TGTAGCCCAGCGAGAGCAGGCTTGGCTCCA-3	
4 5	-CCTGTTGCTGGTGGAGGAATCTACAGTGGG NM053701.1 5594-5653 Cav1.41
TGAAGGATACCTTGGCAAGCTCGGCGGCCC-3	
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immunohistochemical studies of mouse lung tissues using
mouse primary antibodies were confounded by a high back-
ground staining from the endogenousmouse immunoglobulins
in these tissues. The larger ASM preparations from rat, as
expected, produced larger and therefore less ambiguous KCl-
induced contractile responses. Moreover, the larger amount of
ASM tissues obtained from rats facilitated our immunoblot
studies.
Because ASM plays a central role in many respiratory disor-
ders such as asthma and chronic obstructive pulmonary dis-
ease, it has been studied extensively. Moreover, L-type Ca2
channels in ASM play a central role in the Ca2 responses of
ASM, including those provoked by prototypic airway spasmo-
gens, the muscarinic receptor agonists (17, 19). Yet our study is
the first detailed analysis of L-type channel isoforms in ASM.
Similarly, characterizations of L-type channel isoforms have
not been performed on most smooth muscle types despite the
critical roles of the Ca2 channels in regulating vascular tone,
gas exchanges, gastrointestinal peristalsis, and other vital func-
tions. In this study, we used a combination of techniques to
demonstrate that rat ASM expresses multiple isoforms of
L-type channels, as defined by their voltage-sensing, pore-
forming1 subunits. It remains unknownas to the roles of these
L-type channel isoforms in ASM. We speculate that the multi-
ple Cav1 isoforms in ASM, possibly pairing with the corre-
sponding isoform of RyRs, may play a role in the graded con-
tractile responses of ASM to incremental doses of airway
spasmogens as these different Cav1 isoforms have different
thresholds and/or mechanisms of activation (31).
Although it is difficult to make firm conclusions regarding
the relative expression of various L-type channel isoforms, we
noted that the expression of Cav1.31 in the ASM is robust
(Figs. 4 and 5). Whether Cav1.31 in ASM may be functionally
coupled to RyRs is not known and thus will require further
studies. Although the functional role of Cav1.31 in ASM
remains unknown, the existence of Cav1.31 in ASM helps
explain previous findings that L-type channels in the ASM can
be activated at a relatively more negative potential (32).
Cav1.31 has been shown to be activated at membrane poten-
tials 15–25 mV more hyperpolarized than Cav1.21 (33, 34).
Unlike knocking out Cav1.1 or Cav1.2, knocking out Cav1.3 is
not lethal (27). Thus, studyingmice deficient in Cav1.3 could be
helpful in further assessing the functions of this L-type channel
isoform in ASM and in other smooth muscle types.
Our findings suggesting that Cav1.1 and RyR1 are function-
ally coupled in ASM also have other implications. In skeletal
muscle, the physical coupling of these two Ca2 channels not
only allows EC coupling; reciprocal activation of CaV1.1 by
RyR1 also facilitates Ca2 entry into skeletal muscle to replen-
ish intracellular Ca2 stores (35, 36). This type of reciprocal
activation of L-type channels by RyRs has also been described in
neurons (37). Since it has been reported previously that musca-
rinic agonist-induced contraction of ASM requires replenish-
ment of intracellular Ca2 stores by L-type channels (38–40), a
functional coupling of RyR1 andCav1.1may subserve to replen-
ish Ca2 stores in ASM in muscarinic agonist-induced
bronchoconstriction.
In summary, we have found that ASM expresses multiple
isoforms of L-type channels, and at least one of these isoforms is
functionally coupled to the RyRs in ASM. As we already
FIGURE 7. Co-localization of RyR1 and Cav1.31 in cultured rat ASM cells. Cultured rat ASM cells expressed a profile of Ca
2 channel mRNAs similar to that
of ASM shown in Fig. 4 (A). CaV1.11  1S; CaV1.21  1C; CaV1.31  1D; and CaV1.4 1  1F. In these cells, RyR1 (pseudo-red fluorescence) and CaV1.11
(pseudo-green fluorescence) appear to have a similar distribution and are overlapped in areas near the cell membrane (B, arrows). Control cells were probed with
both secondary antibodies but without the primary antibodies.
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described that ASM expresses all three RyR isoforms, we con-
clude that this tissue contains all of the Ca2 channels required
for EC coupling in skeletal and cardiac muscles. Since both
L-type channels and RyRs play vital roles in such important
pathophysiological processes such as bronchoconstriction and
hypoxia-induced pulmonary vasoconstriction, collectively, our
data suggest that the mechanisms of EC coupling in skeletal
muscle and cardiac muscle may also be exploited by various
smooth muscle types to effect their diverse functions.
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